Engineers Gate Manager’s Apellis Pharmaceuticals APLS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.02M | Buy |
58,718
+16,546
| +39% | +$286K | 0.01% | 1108 |
|
2025
Q1 | $922K | Buy |
+42,172
| New | +$922K | 0.02% | 1109 |
|
2024
Q4 | – | Sell |
-67,625
| Closed | -$1.95M | – | 2208 |
|
2024
Q3 | $1.95M | Buy |
67,625
+55,456
| +456% | +$1.6M | 0.04% | 664 |
|
2024
Q2 | $467K | Buy |
12,169
+6,120
| +101% | +$235K | 0.01% | 1256 |
|
2024
Q1 | $356K | Buy |
6,049
+2,221
| +58% | +$131K | 0.01% | 1377 |
|
2023
Q4 | $229K | Sell |
3,828
-22,533
| -85% | -$1.35M | 0.01% | 1580 |
|
2023
Q3 | $1M | Buy |
26,361
+22,846
| +650% | +$869K | 0.04% | 706 |
|
2023
Q2 | $320K | Buy |
+3,515
| New | +$320K | 0.01% | 1279 |
|
2022
Q2 | – | Sell |
-10,678
| Closed | -$543K | – | 1884 |
|
2022
Q1 | $543K | Buy |
+10,678
| New | +$543K | 0.02% | 1026 |
|
2021
Q2 | – | Sell |
-7,530
| Closed | -$323K | – | 1583 |
|
2021
Q1 | $323K | Sell |
7,530
-1,760
| -19% | -$75.5K | 0.02% | 1271 |
|
2020
Q4 | $531K | Buy |
+9,290
| New | +$531K | 0.02% | 943 |
|